218 related articles for article (PubMed ID: 35766294)
1. Utility of Updated Japanese Circulation Society Guidelines to Diagnose Isolated Cardiac Sarcoidosis.
Sato K; Kawamatsu N; Yamamoto M; Machino-Ohtsuka T; Ishizu T; Ieda M
J Am Heart Assoc; 2022 Jul; 11(13):e025565. PubMed ID: 35766294
[TBL] [Abstract][Full Text] [Related]
2. Utility of new FDG-PET/CT guidelines for diagnosing cardiac sarcoidosis in patients with implanted cardiac pacemakers for atrioventricular block.
Tanabe S; Nakano Y; Ando H; Fujimoto M; Onishi T; Ohashi H; Kuno S; Naito K; Waseda K; Takahashi H; Suzuki Y; Fukuta M; Amano T
Sci Rep; 2024 Apr; 14(1):7825. PubMed ID: 38570621
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
4. Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow-up fluorine-18 fluorodeoxyglucose positron emission tomography.
Maeda D; Kanzaki Y; Fujita S; Inuyama M; Takashima S; Miyamura M; Terasaki F; Hoshiga M
ESC Heart Fail; 2019 Aug; 6(4):889-893. PubMed ID: 31264810
[TBL] [Abstract][Full Text] [Related]
5. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of fusion
Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis.
Patel VN; Pieper JA; Poitrasson-Rivière A; Kopin D; Cascino T; Aaronson K; Murthy VL; Koelling T
J Nucl Cardiol; 2022 Oct; 29(5):2460-2470. PubMed ID: 34505261
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
[TBL] [Abstract][Full Text] [Related]
9. The Utility of Whole Body
Giudicatti L; Marangou J; Nolan D; Dembo L; Baumwol J; Dwivedi G
Heart Lung Circ; 2020 Jan; 29(1):e1-e6. PubMed ID: 31501049
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT.
Okada T; Kawaguchi N; Miyagawa M; Matsuoka M; Tashiro R; Tanabe Y; Kido T; Miyoshi T; Higashi H; Inoue T; Okayama H; Yamaguchi O; Kido T
J Nucl Cardiol; 2023 Feb; 30(1):280-289. PubMed ID: 35804283
[TBL] [Abstract][Full Text] [Related]
11. Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis.
Vis R; Mathijssen H; Keijsers RGM; van de Garde EMW; Veltkamp M; Akdim F; Post MC; Grutters JC
J Nucl Cardiol; 2023 Aug; 30(4):1543-1553. PubMed ID: 36640249
[TBL] [Abstract][Full Text] [Related]
12. Pre-Treatment Myocardial
Subramanian M; Swapna N; Ali AZ; Saggu DK; Yalagudri S; Kishore J; Swamy LTN; Narasimhan C
JACC Cardiovasc Imaging; 2021 Oct; 14(10):2008-2016. PubMed ID: 33454258
[TBL] [Abstract][Full Text] [Related]
13. Optimal Timing of Serial
Ishizuka M; Kashimura T; Watanabe M; Kase M; Sakai R; Okubo T; Fujiki S; Takayama T; Ishihara S; Ozaki K; Inomata T
Int Heart J; 2023 Mar; 64(2):196-202. PubMed ID: 36927938
[TBL] [Abstract][Full Text] [Related]
14. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
Osborne MT; Hulten EA; Singh A; Waller AH; Bittencourt MS; Stewart GC; Hainer J; Murthy VL; Skali H; Dorbala S; Di Carli MF; Blankstein R
J Nucl Cardiol; 2014 Feb; 21(1):166-74. PubMed ID: 24307261
[TBL] [Abstract][Full Text] [Related]
15. [
Borges-Rosa J; Oliveira-Santos M; Silva R; Gomes A; de Almeida J; Costa G; Gonçalves L; Ferreira MJ
Int J Cardiol; 2022 Jan; 347():38-43. PubMed ID: 34736982
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of isolated cardiac sarcoidosis based on new guidelines.
Kawai H; Sarai M; Kato Y; Naruse H; Watanabe A; Matsuyama T; Takahashi H; Motoyama S; Ishii J; Morimoto SI; Toyama H; Ozaki Y
ESC Heart Fail; 2020 Oct; 7(5):2662-2671. PubMed ID: 32578957
[TBL] [Abstract][Full Text] [Related]
17. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
[TBL] [Abstract][Full Text] [Related]
18. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
Ahmed AI; Abebe AT; Han Y; Alnabelsi T; Agrawal T; Kassi M; Aljizeeri A; Taylor A; Tleyjeh IM; Al-Mallah MH
J Nucl Cardiol; 2021 Aug; 28(4):1545-1552. PubMed ID: 34228337
[TBL] [Abstract][Full Text] [Related]
20. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
